Cite
Evaluation of Methylation Panel in the Promoter Region of p16 INK4a , RASSF1A , and MGMT as a Biomarker in Sputum for Lung Cancer.
MLA
Mohammed, F., et al. “Evaluation of Methylation Panel in the Promoter Region of P16 INK4a , RASSF1A , and MGMT as a Biomarker in Sputum for Lung Cancer.” Archives of Razi Institute, vol. 77, no. 3, June 2022, pp. 1075–81. EBSCOhost, https://doi.org/10.22092/ARI.2022.357985.2131.
APA
Mohammed, F., Baydaa Abed Hussein, A., & Ahmed, T. (2022). Evaluation of Methylation Panel in the Promoter Region of p16 INK4a , RASSF1A , and MGMT as a Biomarker in Sputum for Lung Cancer. Archives of Razi Institute, 77(3), 1075–1081. https://doi.org/10.22092/ARI.2022.357985.2131
Chicago
Mohammed, F, A Baydaa Abed Hussein, and T Ahmed. 2022. “Evaluation of Methylation Panel in the Promoter Region of P16 INK4a , RASSF1A , and MGMT as a Biomarker in Sputum for Lung Cancer.” Archives of Razi Institute 77 (3): 1075–81. doi:10.22092/ARI.2022.357985.2131.